Category: Vaccine Headlines
One arm or two? How you get vaccinated may make a difference
Seattle Times If you’ve presented the same arm for every dose of a particular vaccine, you may want to reconsider. Alternating arms may produce a more powerful immune response, a new study suggests. The researchers studied responses to the first two doses of COVID-19 vaccines. Those who alternated arms showed a small increase in immunity […]
Feb 6, 2024
Cameroon starts world-first malaria mass vaccine rollout
BBC Video The world’s first routine vaccine programme against malaria has started in Cameroon, in a move projected to save thousands of children’s lives across Africa. The symbolic first jab was given to a baby girl named Daniella at a health facility near Yaoundé on Monday. Every year 600,000 people die of malaria in Africa, […]
Jan 23, 2024
Scientists Launch First Human Vaccine Trials For Deadly Nipah Virus
Forbes The University of Oxford announcedThursday that it had launched human trials for a vaccine to protect against the deadly Nipah virus, offering early hope against the dangerous pathogen that experts believe could seed a new pandemic, has no approved vaccines or treatments and kills as many as three in four of the people it infects. The […]
Jan 16, 2024
Low Vaccine Take-Up Blamed for Covid Deaths and Hospitalizations
Bloomberg The UK could have averted more than 7,000 Covid-19 hospitalizations and deaths over a four-month period in 2022 if people had received the recommended number of vaccines. The first British study of its kind, published Monday in the medical journal The Lancet, found that 44% of the population hadn’t gotten enough protective shots by June of […]
Jan 16, 2024
A new COVID vaccine strategy could help — if only people would pay attention
NPR Updated COVID vaccines came to U.S. consumers this fall, promising better protection against recent variants. And there was new messaging too: Get an annual COVID boosters along with your flu shot every fall. But anticipated “high demand” did not materialize. By mid-December, fewer than 20% of US adults had gotten the updated shot, and the CDC warned […]
Dec 26, 2023
Marburg vaccine tested at Texas Biomed moves to Phase 2 clinical trials
Street Insider A Marburg virus vaccine tested at Texas Biomedical Research Institute (Texas Biomed) is progressing in clinical trials, moving a step closer towards becoming the world’s first vaccine against the deadly virus. The Sabin Vaccine Institute recently announced it launched Phase 2 clinical trials of its Marburg virus vaccine, which will initially enroll 125 healthy volunteers in Uganda and Kenya. Early tests […]
Dec 19, 2023
Virginia Tech Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 as a highly infectious virus that spread rapidly and was declared a pandemic by the World Health Organization (WHO) in March of 2020.1 SARS-CoV-2 infection causes respiratory disease (Coronavirus Disease; COVID-19), and during the initial infection wave of the pandemic, disease severity […]
Dec 12, 2023
Novavax’s Updated COVID-19 Vaccine Now Available as Only Option in Poland
Novaxx Novavax’s updated protein-based non-mRNA COVID-19 vaccine is now available for use in Poland for the prevention of COVID-19 in individuals aged 12 and older. Doses have been distributed by the appropriate Polish authorities and made available for this season’s vaccination campaign. The Novavax vaccine is currently the only updated COVID-19 vaccine option available in […]
Dec 12, 2023
Some Reasons to Get Off the Fence About COVID Booster
Medscape Though many people remain on the fence about getting the latest COVID vaccine booster, new research suggests a strong argument for getting the shot this winter: It sharply reduces the risk for COVID. Researchers found that getting vaccinated led to a 69% reduction in long-COVID risk among adults who received three vaccines before being infected. […]
Dec 12, 2023
Two COVID-19 vaccines show robust boosting potential in clinical trial
Medical Express Two Melbourne-made COVID-19 vaccines have shown strong potential to be an improved approach for boosting immunity to SARS-CoV-2 variants according to interim results of a Phase 1 clinical trial. Published in eBioMedicine, 76 healthy adults from Melbourne, aged 18 to 64 who were previously vaccinated with licensed SARS-CoV-2 vaccines, were randomized to receive a fourth dose of […]
Dec 12, 2023